The Comparison of Outcome in Treating Proximal Ureteric Stones of Size 10 mm to 15 mm Using Extracorporeal Shock Wave Lithotripsy as Compared to Ureterorenoscopic Manipulation Using Holmium Laser by Bangash, Kashif et al.
 Journal of Renal and Hepatic Disorders 2021;5(1): 30–37 30
Journal of  Renal and Hepatic Disorders
ORIGINAL ARTICLE: URETHRAL
The Comparison of Outcome in Treating Proximal Ureteric  
Stones of Size 10 mm to 15 mm Using Extracorporeal Shock  
Wave Lithotripsy as Compared to Ureterorenoscopic Manipulation 
Using Holmium Laser
Kashif Bangash1, Arsalan Riaz1, Hassan Mumtaz1,*, Farrukh Zaman1, Inam Malkani1, Muhammad 
Danish Qureshi1, Fayyaz Haider Ali2, Khursheed Anwar3
1KRL Hospital, Islamabad Pakistan; 2Quaid e Azam International Hospital Islamabad, Pakistan; 3PAEC General Hospital, Islamabad, Pakistan
Abstract
Urinary stone disease or nephrolithiasis, the third most common disease of the urinary tract, is a major health issue due to its high prevalence, occur-
rence, and recurrence. The hallmark of a stone that obstructs the ureter or renal pelvis is excruciating, intermittent pain that radiates from the flank 
to the groin or to the inner thigh. Stone size influences the rate of spontaneous stone passage.  Our aim was to compare the efficacy & the frequency 
of stone-free patients after intervention at 1 week after extracorporeal shock wave litho tripsy (ESWL) and ureterorenoscopic (URS) manipulation 
for proximal ureteric stone (10–15 mm size). This randomized control trial was done in the department of Urology, KRL Hospital Islamabad from 
18th Nov 2019 to 18th May 2020. After meeting the inclusion criteria, 100 patients were enrolled and were divided into two groups. The first group 
was treated with ESWL and the other with URS. Then, procedures were done. Follow-up was noted after 1 week in the stone clinic. The average age 
of the patients was 39.71 ± 10.17 years. Efficacy in the ESWL group was found in 68% cases while in the URS group, efficacy was noticed in 76% 
cases (P > 0.05). Male patients were three times at a higher risk of recurrence as compared to females. This study concluded that both ESWL and 
URS are equally effective statistically in terms of the frequency of stone-free patients at 1 week for  proximal ureteric stone (10–15 mm size). 
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Introduction
Urinary stone disease or nephrolithiasis is the third most 
common disease of the urinary tract. It is a major health 
issue due to its high prevalence, occurrence, and recurrence. 
The life-span and frequency of kidney stones for both men 
and women are approximately 13 and 7%, respectively (1).
Ureteral stones may be asymptomatic or the potential 
symptoms include abdominal and flank pain, nausea and 
vomiting, urinary tract obstruction, infection, and proce-
dure-related morbidity. Ureteral stones frequently cause 
renal colic and if  left untreated can cause obstructive urop-
athy (2). According to recent estimates, the prevalence in the 
US population is 10.6% for men and 7.1% for women (3). 
The comparison of outcome in treating proximal ureteric stones
 Journal of Renal and Hepatic Disorders 2021;5(1): 30–37 31
It is estimated that 68% of the stones of about 5 mm size 
and 47% stones of over 5–10 mm size may pass sponta-
neously, and stones of over 10 mm size need intervention (12).
Our objective was to check whether ESWL is safe alterna-
tive to URS or not.
Material and Methods
This Randomized Control Trial was done during 6 months, 
that is, from November 18, 2019, to May 18, 2020, in the 
Department of Urology, KRL Hospital, Islamabad. The 
sample size was calculated using the WHO calculator. Pop-
ulation proportion of clear the stone in group 1 (ESWL) was 
0.492 (10) and population proportion of clear the stone in 
group 2 (URS) was 0.881 (11). Level of significance was 5%, 
and the power of test was 80%.
Sampling technique used was (nonprobability) consecutive 
sampling. The total sample size was 100, which was random-
ized into two groups through the lottery method.
Inclusion criteria
Patients over 16 years of age up to 70 years; both male and 
female patients, having proximal ureteric stone of 10–15 mm 
size with normal renal function (serum creatinine 0.7–1.5 
mg/dL); or patients being diagnosed with solitary proximal 
ureteric stones were included in our study.
Exclusion criteria
Patients with solitary functioning kidney, patients with renal 
failure, pregnant women, patients having deranged coagula-
tion profile, patients with sepsis, patients with any comorbid-
ities, patients with multiple stones, or patients having severe 
hydronephrosis (renal pelvis > 6 mm diameter and cortex 
< 1 cm on ultrasound kidney ureter bladder [KUB]) were 
excluded from our study.
Data collection procedure
Patients who fulfilled the inclusion criteria from indoor and 
outdoor departments of Urology, KRL Hospital, Islam-
abad, were included in the study after obtaining permission 
from the Ethical Committee and the Research Department 
of Urology, KRL Hospital, Islamabad. A detailed expla-
nation about the procedure was given to the patients and a 
written informed consent was obtained explaining the risks 
and benefits of the study.
Computed tomography (CT) scan KUB plain was done in 
patients for follow-up. ESWL patients had a single session. 
Time frame from presentation to treatment in each group 
was 1 week. Patients in the URS group were stunted during 
the procedure. ESWL patients commonly require many 
Prevalence of stones is 4–20% and incidence is 0.03–0.1%, in 
adults (4).
Extracorporeal shock wave lithotripsy (ESWL) and uret-
erorenoscopy (URS) are the two methods for treating prox-
imal ureteric stones. Surgeons infrequently perform open 
surgery. ESWL is a well-recognized standard procedure that 
is particularly effective with small renal stones (≤20 mm). It 
is commonly performed as an outpatient procedure with a 
low complication rate and requires no anesthesia. Its effi-
cacy can be compromised by obesity, stone density, com-
position, size, and location in the kidney. In several studies, 
it is found that ESWL is a safe and acceptable treatment 
option for morbidly obese patients with upper ureteral 
stones (5).
The overall efficacy of ESWL for nephrolithiasis depends 
mainly on stone size, location, stone composition, patient 
habit, and the performance of ESWL.
Reports from high-volume centers with static machines 
suggest stone clearance rates of 86–89%, 71–83%, 73–84%, 
and 37–68% for stones in the renal pelvis, upper calyx, mid-
dle calyx, and lower pole calyx, respectively (6). The use of 
ESWL not only reduced hospitalization time and morbid-
ity but is also cost effective (7). The URS is a form of mini-
mally invasive surgery using a small telescope that is passed 
through the urethra and into the ureter to remove a stone.
Laser pneumatic lithoclast is required for fragmentation 
of stones which then allows the smaller pieces to be removed 
with a grasping device. Pneumatic and laser lithotriptors are 
most preferred and most frequently used in intracorporeal 
lithotripsy during endoscopic management of the ureteral 
stone. Holmium Laser lithotripsy gained popularity and 
is established as the standard modality. Holmium laser is a 
kind of new laser commonly used in urological surgery. It 
can crush all kinds of stones, irrespective of their composi-
tion and density. It causes a little ureteral mucosal damage 
and is cost-effective as well (8). A combination of URS and 
intracorporeal lithotripsy has proven to be a viable alterna-
tive to ESWL. However, some urologists recommend URS 
manipulation as the treatment of choice. For proximal ure-
teric stones, the debate still continues as to whether ESWL 
or URS manipulation should be the first-line treatment. 
However, the ESWL is better in terms of decreasing hospital 
stay and there is no requirement of anesthesia. The ESWL 
is desirable in poor countries because of its noninvasive-
ness, low morbidity, and utility in patients unfit for open 
surgery (9).
The purpose of this study was to compare the stone-free 
rate at 1 week after ESWL and URS manipulation in the 
treatment of proximal ureteric stones (10–15 mm size).  Several 
different studies report the success rate of the above two pro-
cedures differently. For example, in one study population, the 
proportion of stone clearance using the ESWL was 0.492 and 
in another group, it was 0.881 using the URS (10, 11).
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Results
In patients treated with ESWL, the mean age of the patients 
was 40.78 ± 10.19 years, whereas in patients treated with 
URS the mean age of the patients was 38.52 ± 10.44 years. 
Thirty-six patients (48%) treated with ESWL were male 
while 14 (56%) were females. Similarly, 39 patients (52%) 
treated with URS were male while 11 (44%) were females. 
In the ESWL group, the mean body mass index (BMI) of 
the patients was 25.24 ± 3.91 kg/m2 while in patients in the 
URS group, the mean BMI of the patients was 25.22 ± 
4.048 kg/m2. In the ESWL group, the left side of location of 
stone was noted in 29 (48.3%) patients and the right site of 
location was noted in 21 (52.5%) patients. Similarly, in the 
URS group, the left side of location was noted in 31 (51.7%) 
patients and the right site of location of stone was noted in 
19 (47.5%) patients as shown in (Tables 1 and 2)
In the ESWL group, the mean stone density in patients 
was 727.54 ± 178.52 while in the URS group, the mean 
stone density of the patients was 869.06 ± 302.22. This dif-
ference was statistically significant, that is, P = 0.005. The 
mean size of stone of the patients in the ESWL group was 
12.57 ± 1.67 mm while in the URS group, the mean size of 
stone of the patients was 12.44 ± 1.67 mm. This difference 
sessions, which is very costly. It causes financial burden and 
psychological trauma for the patients. One session of ESWL 
and follow-up after 1 week was decided upon before continu-
ing with ESWL sessions or shifting to URS.
Data analysis
Data were entered and analyzed in statistical software Statisti-
cal Package for Social Sciences (SPSS), version 22. Frequency 
and percentage were computed for categorical variables like 
age groups, gender, presenting complaints, laterality of stone, 
pain associated with vomiting, and efficacy. Mean and stan-
dard deviation were computed for quantitative measures like 
age, number of stones, and stone size. Chi-square test was 
applied to compare proportion of stone-free rate between 
groups. Gender, age groups, and presenting complaints were 
used for the stratification. After stratification, a Chi-square 
test was applied. P ≤ 0.05 was considered significant.
Work
This work has been reported in line with Consolidated Stan-
dards of Reporting Trials (CONSORT) Guidelines.
Table 1: Summary statistics of age (years), gender, BMI (kg/m2) and frequency distribution of side of stone between  
study groups.





Standard Deviation 10.19 10.44
Gender Male 36 39 75
48.0% 52.0% 100.0%
Female 14 11 25
56.0% 44.0% 100.0%
BMI (kg/m2) n 50 50
Mean 25.24 25.22
Standard Deviation 3.91 4.048
Site of stone Left 29 31 60
48.3% 51.7% 100.0%
Right 21 19 40
52.5% 47.5% 100.0%
BMI = body mass index; ESWL = extracorporeal shock wave lithotripsy; URS = ureterorenoscopy.
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was statistically insignificant, that is, P = 0.692 as as shown 
in (Table 3)
In the ESWL group, efficacy was achieved in 34 (68%) 
patients, while in the URS group, efficacy was achieved in 38 
(76%) patients. This difference was statistically insignificant, 
that is, P = 0.373, according to our Table 3.
Statistically insignificant difference was found between 
the study groups and efficacy of the patients stratified by age 
and gender, that is, site and size of stone and stone density in 
Table 4,, that is, P > 0.05.
Discussion
Our randomized control trial was conducted at the Depart-
ment of Urology, KRL Hospital, Islamabad, to compare 
the efficacy (frequency of stone-free patients) at 1 week after 
ESWL and the URS manipulation for proximal ureteric 
stone (10–15 mm size).
The ESWL and the URS are currently accepted treatment 
modalities for distal ureteral calculi. Some investigators favor 
Table 2: Comparison of density and size (mm) of stone between study groups.
Variable and Subcategories Efficacy Study Groups Total P
ESWL URS
Stone size 10–12 Yes 16 15 31 0.609
69.6% 62.5% 66.0%
No 7 9 16
30.4% 37.5% 34.0%
13–15 Yes 12 12 24 0.092
66.7% 92.3% 77.4%
No 6 1 7
33.3% 7.7% 22.6%
Stone density ≤ 800 Yes 21 13 34 0.710
70.0% 65.0% 68.0%
No 9 7 16
30.0% 35.0% 32.0%
>800 Yes 13 25 38 0.137
65.0% 83.3% 76.0%
No 7 5 12
35.0% 16.7% 24.0%
ESWL = extracorporeal shock wave lithotripsy; URS = ureterorenoscopy.
the ESWL while others (8–10) prefer the URS. For both treat-
ment modalities, stone-free rates of more than 90% have been 
reported (13).
The American Urological Association Ureteral Stones Clin-
ical Guidelines Panel has found both ESWL and URS to be 
acceptable treatment options for the patients, based on the stone-
free results, morbidity, and re-treatment rates for each respective 
therapy (13).
Urolithiasis is one of the leading causes of morbidity of 
the urinary tract system globally. In the last few decades, the 
treatment of urinary tract stones has been revolutionized 
with the introduction of minimally invasive techniques. For 
a few decades, the ureteral stones were managed by open 
ureterolithotomy. Then, with time, there was refinement of 
the semirigid URS, the ESWL machines, laparoscopic proce-
dures, and the flexible URS, resulting in an enormous change 
in the management of ureteral stones (14, 15).
The number of previous randomized trials of the URS 
versus the ESWL for proximal ureteric stone is very lim-
ited (16). Most of them were retrospective in design. These 
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Table 3: Comparison of density, size of stone (mm), and outcome between study groups.
Variable and Subcategories Study Groups P
ESWL URS
Density n 50 50 0.005
Mean 727.54 869.06
Standard Deviation 178.52 302.22
Size of stone (mm) n 50 50 0.692
Mean 12.57 12.44
Standard Deviation 1.67 1.65




ESWL = extracorporeal shock wave lithotripsy; URS = ureterorenoscopy.
retrospective reviews have been the only evidence for advo-
cating the merits of one treatment over the other.
In this study, the average age of the patients was 39.71 ± 
10.17 years. In patients treated with the ESWL, the mean age 
of the patients was 40.78 ± 10.19 years, whereas in patients 
treated with the URS, the mean age of the patients was 38.52 ± 
10.44 years. Male-to-female ratio of the patients was 3:1. 
Among patients treated with the ESWL, 36 (48%) were male, 
while 14 (56%) were females. Similarly, in patients treated with 
the URS, 39 (52%) were male while 11 (44%) were females.
According to Manzoor et al., the average age of the 
patients was 42.54 ± 14.07 years. There were 289 (72.6%) 
males and 109 (27.4%) females (11). Another study by 
Iqbal et al. (17) showed that the mean age in ESWL and 
URS groups was 39.21 ± 13.36 and 43.13 ± 13.65 years, 
respectively. Mean stone size was 10.47 ± 3.7 mm (ESWL) 
and 13.6 ± 6.6 mm (URS). There were no significant dif-
ferences regarding age, gender, BMI, and the comorbidities 
of patients in both groups. Hatroom demonstrated that out 
of 90 patients, there were 64 (71.1%) males and 26 (28.9%) 
females with a male-to-female ratio of 2.5:1. Their age 
ranged from 17 to 58 years and the mean age was 36.9 ± 11.7 
years (18).
The available literature on ureteral stone disease shows 
that males are at the greatest risk of developing urolithiasis. 
The incidence rate among men is two times higher and the 
prevalence rate about four times higher compared to women 
(19). In the developing countries, the male-to-female ratio 
ranges from 1.15:1 in Iran (14) and 1.6:1 in Thailand (20) to 
2.5:1 in Iraq (21) and 5:1 in Saudi Arabia (22).
In our study, efficacy was achieved in 72 (72%) patients. In 
the ESWL group, efficacy was achieved in 34 (68%) patients 
while in the URS group, efficacy was achieved in 38 (76%) 
patients. Although this difference was statistically insignifi-
cant, the URS group in our study showed higher efficacy as 
compared to the ESWL group. Some of the studies are dis-
cussed below with their respective results.
Reports from high-volume centers with static machines 
suggest stone clearance rates of 86–89%, 71–83%, 73–84%, 
and 37–68% for stones in the renal pelvis, upper calyx, mid-
dle calyx, and lower pole calyx, respectively (6).
Saleem achieved stone-free rate of 88% with URS and 60% 
with ESWL for stone size greater than or equal to 1 cm (23). 
One study by Manzoor et al. (11) documented that success rate 
was 49.2% for ESWL and 57.8% for URS (P = 0.008). The 
re-treatment rate was significantly higher in the ESWL group 
than in the URS group (40% vs. 11 and 18% in URS group).
Fong et al. experienced an overall stone-free rate of 50% in 
ESWL and 80% in URS (24). Wu et al. suggested that URS 
achieved excellent results and should be considered as first-
line therapy for proximal ureteric stones greater than 1 cm 
in size (25).
In one study, the success and stone-free rate after ESWL 
was 85%, while it was 100% in the URS group. There was sta-
tistical significance between the two treatment groups (18).
Kawano et al. found that 83.6% of patients with proximal 
ureteric stones became stone-free after one session of ESWL 
(26). Tawfick achieved a 92% stone-free rate with the uretero-
scopic lithotripsy of proximal ureteric stones, and the initial 
stone-free rate for in-situ ESWL was 58% (27).
The comparison of outcome in treating proximal ureteric stones
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Ureteric stones are often more difficult to locate and, 
therefore, more difficult to target with the shock wave. How-
ever, several studies have demonstrated a stone-free rate close 
to 100% for the treatment of proximal ureteral stones with 
ESWL (28). However, stone-free rate appears to decline to 
70% for mid-ureteral stone for many lithotripters (29).
Andreoni et al. (21) used the URS to treat patients with 
stone size less than 15 mm and achieved an initial stone-free 
rate of 70%. While shock wave application is contraindicated 
Table 4: Comparison of outcome between study groups stratified by age, gender, and site of stone.
Variable Subcategory Efficacy Study Groups Total P
ESWL URS
Age (years) ≤ 30 Yes 5 12 17 0.115
50.0% 80.0% 68.0%
No 5 3 8
50.0% 20.0% 32.0%
>30 Yes 29 26 55 1.000
72.5% 74.3% 73.3%
No 11 9 20
27.5% 25.7% 26.7%
Gender Male Yes 24 30 54 0.323
66.7% 76.9% 72.0%
No 12 9 21
33.3% 23.1% 28.0%
Female Yes 10 8 18 0.943
71.4% 72.7% 72.0%
No 4 3 7
28.6% 27.3% 28.0%
Stone site Left Yes 17 22 39 0.316
58.6% 71.0% 65.0%
No 12 9 21
41.4% 29.0% 35.0%
Right Yes 17 16 33 0.787
81.0% 84.2% 82.5%
No 4 3 7
19.0% 15.8% 17.5%
ESWL = extracorporeal shock wave lithotripsy; URS = ureterorenoscopy.
during pregnancy, Lifshitz et al. successfully treated 10 
pregnant women by using ureteroscopy and intracorporeal 
lithotripsy and did not note any obstetric or urological com-
plications (30).
Urologists who favor URS claim that although it is an inva-
sive procedure, it has, in contrast to ESWL, a greater success 
rate at the first treatment session. Patient preference should 
always be a great concern. Some patients might have certain 
fears regarding the anesthesia required and the invasiveness 
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systematic review. J Endourol. 2017;31(6):547–556. https://doi.
org/10.1089/end.2016.0895
11. Manzoor S, Hashmi AH, Sohail MA, Mahar F, Bhatti S, 
Khuhro AQ. Extracorporeal shock wave lithotripsy (ESWL) 
vs. ureterorenoscopic (URS) manipulation in proximal ureteric 
stone. J Coll Physicians Surg Pak. 2013;23(10):726–730.
12. Preminger GM, Tiselius H-G, Assimos DG, Alken P, Buck C, 
Gallucci M, et al. 2007 guideline for the management of ureteral 
calculi. J Urol. 2007;178(6):2418–2434. https://doi.org/10.1016/j.
juro.2007.09.107
13. Ghalayini IF, Al-Ghazo MA, Khader YS. Extracorporeal shock-
wave lithotripsy versus ureteroscopy for distal ureteric calculi: 
Efficacy and patient satisfaction. Int Braz J Urol. 2006;32(6):656–
667. https://doi.org/10.1590/S1677-55382006000600006
14. Kumar A, Vasudeva P, Nanda B, Kumar N, Jha SK, Singh H. 
A prospective randomized comparison between laparoscopic 
ureterolithotomy and semirigid ureteroscopy for upper ure-
teral stones > 2 cm: A single-center experience. J Endourol. 
2015;29(11):1248–1252. https://doi.org/10.1089/end.2013.0791
15. Iqbal N, Assad S, Bhatti JRA, Hasan A, Shabbir MU, Akhter S. 
Comparison of extracorporeal shock wave lithotripsy for uro-
lithiasis between children and adults: A single centre study. 
Cureus. 2016;8(9):e810. https://doi.org/10.7759/cureus.810
16. Lee Y-H, Tsai J-Y, Jiaan B-P, Wu T, Yu C-C. Prospective ran-
domized trial comparing shock wave lithotripsy and uretero-
scopic lithotripsy for management of large upper third ureteral 
stones. Urology. 2006;67(3):480–484. https://doi.org/10.1016/j.
urology.2005.09.067
17. Iqbal N, Malik Y, Nadeem U, Khalid M, Pirzada A, Majeed M, 
et al. Comparison of ureteroscopic pneumatic lithotripsy and 
extracorporeal shock wave lithotripsy for the management of 
proximal ureteral stones: A single center experience. Turk J 
Urol. 2018;44(3):221. https://doi.org/10.5152/tud.2018.41848
18. Hatroom AAS. Extracorporeal shock wave lithotripsy and ure-
terorenoscopy procedures of ureteric stone disease in patients 
with a solitary kidney in Aden. Dev Prim Health Care Syst State 
Qatar. 2019;7(10):12.
19. Trinchieri A. Epidemiology of urolithiasis: An update. Clin 
Cases Miner Bone Netabol. 2008;5(2):101.
20. Tanthanuch M, Apiwatgaroon A, Pripatnanont C. Urinary tract 
calculi in southern Thailand. J Med Assoc Thai. 2005;88(1):80–85.
21. Qaader D, Yousif  S, Mahdi L. Prevalence and etiology of 
urinary stones in hospitalized patients in Baghdad. Eastern 
Mediterranean Health J. 2006;12(6):853–861.
22. Khan AS, Rai ME, Pervaiz A, Shah AH, Hussain AA, 
Siddiq  M. Epidemiological risk factors and composition of 
urinary stones in Riyadh Saudi Arabia. J Ayub Med Coll 
Abbottabad. 2004;16(3):56–58.
23. Salem HK. A prospective randomized study comparing shock 
wave lithotripsy and semirigid ureteroscopy for the management 
of proximal ureteral calculi. Urology. 2009;74(6):1216–1221. 
https://doi.org/10.1016/j.urology.2009.06.076
24. Fong Y, Ho S, Peh O, Ng F, Lim P, Quek P, et al. Extracorporeal 
shockwave lithotripsy and intracorporeal lithotripsy for proxi-
mal ureteric calculi-a comparative assessment of efficacy and 
safety. Ann Acad Med Singapore. 2004;33(1):80–83.
25. Wu C-F, Shee J-J, Lin W-Y, Lin C-L, Chen C-S. Comparison 
between extracorporeal shock wave lithotripsy and semirigid 
ureterorenoscope with holmium: YAG laser lithotripsy for treat-
ing large proximal ureteral stones. J Urol. 2004;172(5):1899–
1902. https://doi.org/10.1097/01.ju.0000142848.43880.b3
of URS. Others might prefer to have the stone removed and 
the pain alleviated more rapidly without the possibility of 
multiple treatment sessions and prolonged stone clearance 
period such as with the ESWL. The availability of the equip-
ment, experience of the surgeon with both modalities, and 
the patient preference will determine the choice (11).
Conclusion
This study concluded that both ESWL and URS are equally 
effective statistically in terms of the frequency of stone-free 
patients at 1 week for proximal ureteric stones (10–15 mm 
size). Although the difference is insignificant, the URS group 
showed higher stone-free frequency than the ESWL group.
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